Dr. Raffit Hassan on Avelumab in Unresectable Mesothelioma
October 12th 2015
Raffit Hassan, MD, Co-Chief Thoracic and Gastrointestinal Oncology Branch, Senior Investigator Head, Thoracic and Solid Tumor Immunotherapy Section at the Center for Cancer Research,
National Cancer Institute, discusses a recent phase IB trial investigating avelumab in unresectable mesothelioma.